Stockwatch: A Turn Of The Biotech Page
This article was originally published in Scrip
In the bad old days before antibiotics and antimicrobial agents, patients only had their immune systems with which to fight infections. An antibacterial antibody response might take over a week to elicit but when the temperature of a patient with a systemic infection finally started to normalize, they could have been said to have turned the page, even if they were not yet out of the woods. There were some signs last week that the biotech fever that started in the summer of 2015 might be breaking.